Pivotal trials and novel combinations have started, but four programmes seem to have been discontinued.
ApexOnco Front Page
Recent articles
16 March 2026
Varseta-M efficacy wanes, but more than justifies a pivotal trial.
1 December 2025
Car-T therapies and ADCs feature among recent first-in-human study entrants.
1 December 2025
The agency approved eight oncology products over the month.
28 November 2025
Varegacestat’s pivotal study reads out imminently.
28 November 2025
The group will take HRS-4642 into a Chinese phase 3 in first-line pancreatic cancer.
28 November 2025
The pivotal Harmoni-GI3 study has started enrolling patients.